Avadel Pharmaceuticals plc - Ordinary Share (NQ:AVDL)

21.64 UNCHANGED

Last Price Updated: 4:00 PM EST, Feb 11, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Avadel Pharmaceuticals plc - Ordinary Share

< Previous 1 2 3 4 5 6 Next >

Avadel Pharmaceuticals plc (AVDL) Q3 2021 Earnings Call Transcript ↗

November 08, 2021

AVDL earnings call for the period ending September 30, 2021.

Via The Motley Fool

Topics Earnings

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

October 27, 2021

Gainers Bio-Path Holdings (NASDAQ:BPTH) shares moved upwards by 9.69% to $5.43 during Wednesday's pre-market session. The company's market cap stands at $37.7...

Via Benzinga

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

October 25, 2021

Gainers Kiromic BioPharma (NASDAQ:KRBP) stock increased by 28.64% to $2.47 during Monday's pre-market session. The company's market cap stands at $38.1 million....

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

October 19, 2021

Gainers Entasis Therapeutics Hldg (NASDAQ:ETTX) shares moved upwards by 16.72% to $3.63 during Tuesday's pre-market session. The company's market cap stands at $...

Via Benzinga

The Week Ahead In Biotech (Aug. 8-14): Jazz Pharma FDA Decision, Earnings Deluge and IPOs In The Spotlight ↗

August 08, 2021

Biopharma stocks ended higher for the week ending Aug. 6, as the sector latched on to the optimism that was evident in the broader markets. Earnings continued to flow in,...

Via Benzinga

46 Biggest Movers From Yesterday ↗

October 19, 2021

Gainers Valneva SE (NASDAQ: VALN) shares surged 39.8% to close at $39.21 on Monday after the company reported VLA2001 met both co-primary endpoints in the Phase 3 pivotal trial...

Via Benzinga

Why Shares of Avadel Are Sinking Today ↗

October 18, 2021

A key regulatory decision is overdue, leaving shareholders to wonder when it might arrive.

Via The Motley Fool

34 Stocks Moving In Monday's Mid-Day Session ↗

October 18, 2021

Gainers Valneva SE (NASDAQ: VALN) shares jumped 34.6% to $37.75 after the company reported VLA2001 met both co-primary endpoints in the Phase 3 pivotal trial Cov-Compare....

Via Benzinga

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

October 18, 2021

Gainers Valneva (NASDAQ:VALN) stock increased by 35.65% to $38.05 during Monday's pre-market session. The market value of their outstanding shares is at $1.8 billion....

Via Benzinga

Avadel Shares Fall As FDA Pushes Approval For Its Narcolepsy Treatment Candidate ↗

October 18, 2021

The FDA has notified Avadel Pharmaceuticals plc (NASDAQ: AVDL) that the review of its marketing application for FT218 is still ongoing, and action will likely not...

Via Benzinga

The Week Ahead In Biotech (Oct. 18-23): J&J, Biogen Kickstart Big Pharma Earnings, Regeneron-Sanofi, Roche Await FDA Decisions And IPOs ↗

October 18, 2021

Biotech stocks rebounded in the week ended Oct. 15, bouncing from third straight weekly losses. The strength came amid a broader market rally and some sector-specific news....

Via Benzinga

21 Stocks Moving in Monday's Pre-Market Session ↗

October 18, 2021

Gainers Valneva SE (NASDAQ: VALN) rose 34.4% to $37.69 in pre-market trading after the company disclosed positive Phase 3 results for inactivated, adjuvanted COVID-19 vaccine...

Via Benzinga

51 Biggest Movers From Friday ↗

October 18, 2021

Gainers LM Funding America, Inc. (NASDAQ: LMFA) shares jumped 38.1% to close at $4.75 on Friday after declining around 15% on Thursday. The company recently announced it...

Via Benzinga

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

October 15, 2021

Gainers Sonoma Pharmaceuticals (NASDAQ:SNOA) shares moved upwards by 29.96% to $7.72 during Friday's pre-market session. The company's market cap stands at $20.8...

Via Benzinga

The Daily Biotech Pulse: Moderna's Booster Shot Gets FDA Panel Backing, Decision Day For Avadel, Silence Therapeutics Strikes Licensing Deal, MiNK IPO ↗

October 15, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus Adcom Recommends Approval Of Moderna's COVID-19 Vaccine Booster Shot For...

Via Benzinga

22 Stocks Moving in Friday's Pre-Market Session ↗

October 15, 2021

Gainers LM Funding America, Inc. (NASDAQ: LMFA) rose 39.5% to $4.80 in pre-market trading after declining around 15% on Thursday. The company recently announced it purchased an...

Via Benzinga

15 Stocks Moving in Monday's Pre-Market Session ↗

October 11, 2021

Gainers Trevi Therapeutics, Inc. (NASDAQ: TRVI) rose 32.5% to $1.59 in pre-market trading after the company filed Friday to withdraw its offering of shares. Nutriband Inc. (...

Via Benzinga

The Week Ahead In Biotech (Oct. 10-16): Avadel FDA Decision, Conference Presentations And IPOs Take Center Stage ↗

October 10, 2021

Biotech stocks retreated in the week ending Oct. 8, extending losses for the third straight week. Some of the selling in the space was due to money moving out of defensive...

Via Benzinga

Attention Biotech Investors: Mark Your Calendar For October PDUFA Dates ↗

October 01, 2021

Following a mixed month for regulatory approvals, biotech investors now turn toward a month of plenty as far as Food and Drug Administration decisions are concerned. Four new...

Via Benzinga

The Daily Biotech Pulse: J&J Files For Booster Dose Authorization, Gemini Restructures, Strata Skin CFO Departs, Kaleido Reports Positive Readout ↗

October 05, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct. 4) Avadel Pharmaceuticals plc (...

Via Benzinga

The Daily Biotech Pulse: AbbVie's Migraine Drug OK'd By FDA, Amicus Spins Off Gene Therapy Business, Geovax In-Licenses Cancer Drug ↗

September 29, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Click here for accessing Benzinga's FDA Calendar Scaling The Peaks (Biotech Stocks...

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

September 28, 2021

Gainers Sonoma Pharmaceuticals (NASDAQ:SNOA) shares increased by 35.02% to $7.22 during Tuesday's regular session. Trading volume for this security as of 12:30 EST is...

Via Benzinga

Needham Initiates Coverage With Buy For This Narcolepsy Player ↗

September 23, 2021

Needham

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For September 23, 2021 ↗

September 23, 2021

Upgrades Barclays upgraded the previous rating for Warner Music Group Corp (NASDAQ:

Via Benzinga

Avadel Pharmaceuticals plc (AVDL) Q2 2021 Earnings Call Transcript ↗

August 09, 2021

AVDL earnings call for the period ending June 30, 2021.

Via The Motley Fool

Topics Earnings

12 Health Care Stocks Moving In Friday's After-Market Session ↗

May 14, 2021

Gainers Evaxion Biotech (NASDAQ:EVAX) sha...

Via Benzinga

Avadel Pharmaceuticals plc (AVDL) Q1 2021 Earnings Call Transcript ↗

May 10, 2021

AVDL earnings call for the period ending March 31, 2021.

Via The Motley Fool

Topics Earnings

Avadel's Formulated Sodium Oxybate Shows Improved Sleepiness, Sleep Quality In Narcolepsy Patients ↗

April 19, 2021

Avadel Pharmaceuticals Plc (NASDAQ: AVDL) has announced the presentation of secondary endpoint data from the Phase 3 REST-ON trial evaluating FT218 once-...

Via Benzinga

The Week Ahead In Biotech (May 9-15): Heron, Apellis FDA Decisions, Presentations and Earnings ↗

May 09, 2021

Biotech stocks came under pressure in the week ended May 7 as traders digested a slew of earnings news flow and a handful of clinical trial readouts. COVID-19 vaccine stocks came...

Via Benzinga

< Previous 1 2 3 4 5 6 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.